Cargando…
Therapeutic effect and adverse reaction of sorafenib in the treatment of advanced renal cancer
Efficacy and safety of sorafenib in patients with advanced renal cancer were evaluated. Seventy-four patients with advanced renal cancer treated with sorafenib + interferon from January 2010 to August 2013 were included as the observation group. Another 53 renal cancer patients treated with interfer...
Autores principales: | Qiu, Juhui, Liu, Dongjian, Yan, Zaichun, Jiang, Wei, Zhang, Qinglei, Li, Ning, Deng, Wentao, Ding, Kejia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6341818/ https://www.ncbi.nlm.nih.gov/pubmed/30675211 http://dx.doi.org/10.3892/ol.2018.9776 |
Ejemplares similares
-
A rare adverse reaction of sorafenib
por: Wang, Wenwu
Publicado: (2012) -
Adverse reactions of sorafenib, sunitinib, and imatinib in treating digestive system tumors
por: Fu, Yali, et al.
Publicado: (2018) -
Nexavar(®)-related adverse reactions: Calabrian (Italy) experience for sorafenib exposition in 2012
por: Cilurzo, Felisa, et al.
Publicado: (2013) -
Sorafenib combined with hepatectomy in patients with intermediate-stage and advanced hepatocellular carcinoma
por: Zhuang, Lei, et al.
Publicado: (2017) -
Tolerance and adverse event profile with sorafenib in Indian patients with advanced hepatocellular carcinoma
por: Ostwal, Vikas, et al.
Publicado: (2017)